Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel method for preparing pimobendan from by-product for synthesizing pimobendan

A technology of pimobendan and by-products, applied in the field of pharmaceutical chemical industry, can solve the problems of many reaction steps, unsuitable for industrialized production and the like, and achieve the effect of reducing production cost

Active Publication Date:
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Since the synthesis process using chlorinated benzene as the starting material involves many reaction steps (13-step reaction) and uses unit reaction operations such as liquid bromine and high-pressure ammoniation, it is not suitable for industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel method for preparing pimobendan from by-product for synthesizing pimobendan
  • Novel method for preparing pimobendan from by-product for synthesizing pimobendan
  • Novel method for preparing pimobendan from by-product for synthesizing pimobendan

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020]

[0021] By-product (chemical name is (5RS)-6-[1-(4-methoxybenzyl)-2-(4-methoxybenzyl)-1 H -Benzimidazol-6-yl]-5-methyl-4,5-dihydro-3(2 H )-pyridazinone) (4.54 g, 10 mmol) was dissolved in a mixed solvent of 50 ml of acetone and 25 ml of water, cerium ammonium nitrate (10.96 g, 20 mmol) was added, and the reaction was stirred at 25°C for 2 hours, and a precipitate was precipitated, filtered , the precipitate was collected, and the obtained solid was washed successively with 100 ml of water and 20 ml of acetone, and dried to obtain 3.03 g of a white solid. Add 45 ml of ethyl acetate to the resulting white solid, stir, heat to reflux for 30 minutes, cool, and filter the resulting white precipitate to obtain 2.94 g of pimobendan, with a yield of 88.1%. m.p: 241.1~242.5℃. 1 H-NMR (500MHz, DMSO-d6) δ: 12.86 (br s, 0.5H), 12.83 (br s, 0.5H), 10.91 (br s, 0.5H), 10.88 (br s, 0.5H), 8.12 ( d, J = 9.0, 2H), 8.02 (br s, 0.5H), 7.85 (br s, 0.5H), 7.73 (d, J = 8.5Hz, 0.5H), 7...

Embodiment 2

[0023] By-product (chemical name is (5RS)-6-[1-(4-methoxybenzyl)-2-(4-methoxybenzyl)-1 H -Benzimidazol-6-yl]-5-methyl-4,5-dihydro-3(2 H )-pyridazinone) (9.08 g, 20 mmol) was dissolved in a mixed solvent of 100 ml of acetone and 50 ml of water, added cerium ammonium nitrate (32.9 g, 60 mmol), stirred at 22°C for 2.5 hours, precipitated, filtered , the precipitate was collected, and the obtained solid was washed successively with 200 milliliters of water and 40 milliliters of acetone, and dried to obtain 6.23 grams of a white solid. Add 90 ml of ethyl acetate to the resulting white solid, stir, heat to reflux for 30 minutes, cool, and filter the resulting white precipitate to obtain 6.01 g of pimobendan, with a yield of 90%.

Embodiment 3

[0025] By-product (chemical name is (5RS)-6-[1-(4-methoxybenzyl)-2-(4-methoxybenzyl)-1 H -Benzimidazol-6-yl]-5-methyl-4,5-dihydro-3(2 H )-pyridazinone) (4.54 g, 10 mmol) was dissolved in a mixed solvent of 50 ml of acetone and 25 ml of water, cerium ammonium nitrate (13.7 g, 25 mmol) was added, and the reaction was stirred at 20°C for 3 hours, a precipitate was precipitated, filtered , the precipitate was collected, and the obtained solid was washed successively with 100 ml of water and 20 ml of acetone, and dried to obtain 3.23 g of a white solid. Add 45 ml of ethyl acetate to the resulting white solid, stir, heat to reflux for 30 minutes, cool, and filter the resulting white precipitate to obtain 3.05 g of pimobendan, with a yield of 91%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel method for preparing pimobendan from a by-product for synthesizing the pimobendan. The method comprises the following steps that the by-product (the chemical name is (5RS)-6-[1-(4-methoxybenzyl)-2-(4-methoxyphenyl)-1H-benzimidazole-6-yl]-5-methyl-4,5-dihydro-3(2H)-pyridazinone) obtained in the pimobendan synthesizing process is dissolved into a mixed solvent and reacts with ceric ammonium nitrate (CAN) at 20-25 DEG C for 2-3 hours so as to obtain a pimobendan crude product; and the obtained pimobendan crude product is heated and refluxed in an organic solvent, and cooling, filtering and drying are carried out so as to obtain the pimobendan. According to the method, the unwanted by-product is converted into a required pimobendan product, waste is turned intowealth, and therefore the production cost is greatly lowered.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical chemistry, in particular to a novel method for preparing pimobendan from by-products of synthesizing pimobendan. Background technique [0002] Pimobendan, also known as Pimobendan (Pimobendan), trade name Acardi®, its chemical name is 4, 5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazole- 5-yl]-5-methyl-3(2H)-pyridazinone was developed by Boechringer Ingelhem in Germany and first listed in Japan in 1994. The pharmacological action of pimobendan is characterized by enhancing the sensitivity of cardiac contractile proteins to calcium ions and inhibiting the activity of phosphodiesterase III (PDE-3), while also having the effect of dilating blood vessels, so it is an ideal positive muscle As a cardiotonic drug, it is clinically used to treat acute and chronic heart failure. Further studies have shown that pimobendan is also used in the treatment of heart failure in pet dogs. With the deepening...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D403/04
CPCC07D403/04Y02P20/55
Inventor 不公告发明人
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com